Swk Holdings Corp is a publicly traded investment company focused on acquiring and managing a diversified portfolio of life science and technology investments
The firm specializes in identifying and financing opportunities in the pharmaceutical and biotechnology sectors, leveraging its expertise to assist in the development of innovative products and therapies. By partnering with emerging companies, Swk aims to drive growth and enhance the value of its investments while contributing to advancements in healthcare and technology.
DALLAS, TX / ACCESS Newswire / March 13, 2025 / SWK Holdings Corporation (NASDAQSWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, today announced that it will issue its fourth quarter and full year 2024 earnings results after the market close on Wednesday, March 19, 2025. The Company will host a conference call to discuss its corporate and financial results on Thursday, March 20, 2025 at 10:00am ET.
DALLAS, TX / ACCESSWIRE / January 6, 2025 / SWK Holdings Corporation (NASDAQSWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, provided today a portfolio update for material events occurring since September 30, 2024.
DALLAS, TX / ACCESSWIRE / July 17, 2024 / SWK Holdings Corporation (NASDAQSWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small and mid-sized commercial-stage companies, today provided a corporate progress update as well as a summary of the achievements of its borrower portfolio companies.
The CNN Money Fear and Greed index moved to the "Neutral" zone on Friday. US stocks closed higher on Friday, also recording gains for the quarter after the Federal Reserve’s preferred gauge of inflation showed a cooler-than-expected rise in prices.
What was Wall Street buzzing about this past week? Let's take a closer look at the top 5 buy calls made by Wall Street’s best analysts during the week of Dec. 26-30, 2022.
